Clarity Pharmaceuticals Statistics
Total Valuation
CLRPF has a market cap or net worth of 771.90 million. The enterprise value is 716.48 million.
| Market Cap | 771.90M |
| Enterprise Value | 716.48M |
Important Dates
The last earnings date was Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 371.93M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.86% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 281.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 124.42 |
| PB Ratio | 13.05 |
| P/TBV Ratio | 13.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.00 |
| EV / Sales | 114.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.89 |
Financial Position
The company has a current ratio of 9.69
| Current Ratio | 9.69 |
| Quick Ratio | 9.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.37% and return on invested capital (ROIC) is -36.51%.
| Return on Equity (ROE) | -54.37% |
| Return on Assets (ROA) | -33.76% |
| Return on Invested Capital (ROIC) | -36.51% |
| Return on Capital Employed (ROCE) | -76.10% |
| Revenue Per Employee | 89,912 |
| Profits Per Employee | -610,908 |
| Employee Count | 69 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CLRPF has paid 273,065 in taxes.
| Income Tax | 273,065 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.56% in the last 52 weeks. The beta is 1.33, so CLRPF's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -56.56% |
| 50-Day Moving Average | 2.31 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 42.07 |
| Average Volume (20 Days) | 4,199 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CLRPF had revenue of 6.20 million and -42.15 million in losses. Loss per share was -0.13.
| Revenue | 6.20M |
| Gross Profit | 6.20M |
| Operating Income | -45.30M |
| Pretax Income | -41.88M |
| Net Income | -42.15M |
| EBITDA | -45.18M |
| EBIT | -45.30M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 55.15 million in cash and n/a in debt, giving a net cash position of 55.15 million.
| Cash & Cash Equivalents | 55.15M |
| Total Debt | n/a |
| Net Cash | 55.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 59.16M |
| Book Value Per Share | 0.18 |
| Working Capital | 59.15M |
Cash Flow
In the last 12 months, operating cash flow was -35.91 million and capital expenditures -119,808, giving a free cash flow of -36.03 million.
| Operating Cash Flow | -35.91M |
| Capital Expenditures | -119,808 |
| Free Cash Flow | -36.03M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -730.16% |
| Pretax Margin | -675.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLRPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.46% |
| FCF Yield | -4.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLRPF has an Altman Z-Score of 77.88 and a Piotroski F-Score of 1.
| Altman Z-Score | 77.88 |
| Piotroski F-Score | 1 |